COLL · US market

Collegium Pharmaceutical Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$711.01mFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E14.84×
Latest-quarter run-rate P/E-11.81×
Trailing P/S0.88×
Latest-quarter run-rate P/S0.89×

Calculation inputs

Trailing earnings
US$47.92m
Latest-quarter run-rate earnings
-US$60.20m
Latest fiscal-year earnings
US$62.87m
Trailing revenue
US$808.21m
Latest-quarter run-rate revenue
US$799.51m
Latest fiscal-year revenue
US$780.57m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • ATGAX · Cantor Fitzgerald Equity Opportunity Fund Class A2.31% weight · Holdings dated 30 June 2026
  • PJP · Invesco Pharmaceuticals ETF2.19% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • IBBQ · Invesco Nasdaq Biotechnology ETF2.12% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PBE · Invesco Biotechnology & Genome ETF2.12% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • XPH · State Street SPDR S&P Pharmaceuticals ETF1.10% weight · Holdings dated 21 August 2026
  • RZG · Invesco S&P SmallCap 600 Pure Growth ETF0.84% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PSMLX · Principal SmallCap Fund Class R60.74% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • SCOW · Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF0.65% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PSCH · Invesco S&P SmallCap Health Care ETF0.57% weight · Holdings dated 31 May 2026
  • DLBMX · MassMutual Small Cap Opportunities Fund Class A0.57% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.